MET and non-small cell lung carcinoma: Yu et al. [22] showed that icotinib-resistant human NSCLC (HCC827) cells produced exosomes with mRNA encoding MET oncogenes that mediate the progression of NSCLC by upregulating alpha-actinin 4 (ACTN4).